Resources
22 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 7/28/2023 (updated 3/26/2024)
Researchers interviewed 20 individuals – clinicians, peer support specialists, cultural practitioners, and others familiar with OUD treatment – in a Minnesota tribal community. The Cascade of Care model measures the quality of outcomes at each stage of treatment, from diagnosis to long-term maintenance, and was first proposed in 1998 as an approach to care for HIV/AIDS.
Posted 7/31/2023 (updated 3/26/2024)
This presentation will cover health equity regarding rural American Indian and Alaska Native (AI/AN) communities' prevention and treatment efforts to address substance use disorder (SUD), including the need for contingency management for stimulants.
Posted 6/29/2022 (updated 3/27/2024)
This webinar will highlight the unique challenges faced by tribal communities in securing safe and secure housing and SUD. The presenters will also discuss how AI/AN communities experience homelessness in relation to the rest of the country
Posted 5/10/2022 (updated 3/27/2024)
Background: Drug checking uses analytical chemistry technologies to report on the composition of drugs from the unregulated market to reduce substance use-related risks, while additionally allowing for monitoring and reporting of the supply. In the context of an overdose crisis linked to fentanyl, we used drug checking data to examine variability within the illicit opioid supply.
Posted 5/11/2022 (updated 3/27/2024)
The rate of drug overdose deaths in the USA has more than tripled since the turn of the century, and rates are disproportionately high among the American Indian/Alaska Native (AI/AN) population. Little is known about the overall historical trends in AI/AN opioid-only and opioid/polysubstance-related mortality. This study will address this gap.
Posted 6/7/2022 (updated 3/27/2024)
The first part of this presentation examined and presented medical/physiological aspects of SUD and an overview of the impact of SUD on a small but vulnerable population. Dr. Parker then provided an overview of recent substance abuse prevention and intervention applications within American Indian and Alaska Native communities. She described the trends regarding opioid overdose among American Indian and Alaska Native communities during the global pandemic and discussed opportunities for addressing opioid overdose prevention in the future.
Posted 4/28/2023 (updated 3/27/2024)
Transportation can be a barrier to health and healthcare in rural communities. The Transportation Technical Assistance Coordination Library (TACL) provides a sustainable methodology and platform for access and findability of rural and tribal transit coordination resources across a diverse range of transportation technical assistance centers and the Federal Transit Administration (FTA). The Community Transportation Database, developed by the National Center for Mobility Management (NCMM), allows you to use a map to explore state and local transportation providers and their related information.
Posted 5/16/2023 (updated 3/27/2024)
Xylazine, a veterinary tranquilizer not approved for human use, has been increasingly identified in parts of the U.S. illicit drug supply.
Posted 2/7/2023 (updated 3/27/2024)
The National Council for Mental Wellbeing announced a toolkit, Public Safety-led Community-oriented Overdose Prevention Efforts (PS-COPE), which provides framework to use to enhance overdose prevention and response in the Black, Indigenous and people of color (BIPOC) communities. The toolkit provides tips, tools, and resources to help integrate this approach into existing overdose prevention and response efforts.
Posted 11/6/2023 (updated 3/28/2024)
The John Hopkins Center for Indigenous Health launched the new Tribal Principles website which offers culturally relevant, Indigenous-centered guidance for Tribes to consider when creating spending plans for the use of Tribal opioid settlements. This work complements the broad state/national settlement guidance led at the Johns Hopkins Bloomberg School of Public Health.